
Gliminyle MV Plus 1mg/500mg/0.3mg Tablet
Marketer
Erinyle Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Gliminyle MV Plus 1mg/500mg/0.3mg Tablet
Gliminyle MV Plus (1mg/500mg/0.3mg) tablets are antidiabetic medications combining drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose. Administer this tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially causing kidney damage, vision loss, neuropathy, and limb complications. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms (sweating, dizziness, headache, tremors) and treat them promptly. Maintain regular meals and carry a fast-acting glucose source (sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your physician of any heart conditions before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose checks, along with blood cell and liver function tests, may be recommended by your physician.
Uses of Gliminyle MV Plus 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Gliminyle MV Plus 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliminyle MV Plus 1mg/500mg/0.3mg tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Gliminyle MV Plus 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gliminyle MV Plus 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliminyle MV Plus 1mg/500mg/0.3mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Gliminyle MV Plus 1mg/500mg/0.3mg Tablet works:
The tablet Gliminyle MV Plus (1 mg/500 mg/0.3 mg) combines three agents to manage diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Gliminyle MV Plus 1mg/500mg/0.3mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gliminyle MV Plus 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks before prescribing this medication. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliminyle MV Plus 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Employing Gliminyle MV Plus 1mg/500mg/0.3mg tablets in individuals with kidney disease carries a high risk and is best avoided. Medical advice is essential. Furthermore, this medication is contraindicated for patients experiencing severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Gliminyle MV Plus 1mg/500mg/0.3mg tablets cautiously. Dosage modification may be necessary. Consult a physician. Low initial doses are generally recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Gliminyle MV Plus 1mg/500mg/0.3mg Tablet :
Should you forget a Gliminyle MV Plus 1mg/500mg/0.3mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliminyle MV Plus 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
